Dr. Sridevi Rajeeve, MD
- Medicare services, 2024
- 375
- Medicare patients, 2024
- 104
- Part D claims, 2024
- 462
- Publications
- 19
- MIPS score, 2024
- 83
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Rajeeve's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Sridevi Rajeeve is a hematologist and oncologist in New York, New York
Dr. Rajeeve practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Rajeeve's NPI, 1154843944, was assigned on July 13, 2017. Dr. Rajeeve graduated from Mahatma Gandhi University in 2015. Dr. Rajeeve holds New York license 311082.
- NPI
- 1154843944NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7719228055
- NPI enumeration date
- July 13, 2017
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 37
- Medical school graduation
- 2015
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Sridevi Rajeeve practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Rajeeve's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Sridevi Rajeeve is affiliated with 4 sites of care and 3 medical groups
Dr. Rajeeve's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Hematology Lymphoma Group. Dmand AI also links Dr. Rajeeve to 3 more group practices and clinics and 2 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Sridevi Rajeeve's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rajeeve practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +3 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Sridevi Rajeeve is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Rajeeve's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rajeeve is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Clinical focus
Dmand AI lists multiple myeloma among the conditions Dr. Rajeeve treats.
Hematologists and oncologists near Dr. Rajeeve
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Sridevi Rajeeve billed Medicare for 375 services in 2024
CMS data shows 375 Medicare services from Dr. Rajeeve across 6 procedure codes in 2024, for 104 Medicare patients. Medicare paid $40,230 for them.
Dr. Rajeeve's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 612024: 325433%
- Other services
- 2023: 02024: 50
Where Dr. Rajeeve's Medicare services took place, 2024
- In an office25167%
- In a facility12433%
Dr. Rajeeve compared with the New York median for hematologists and oncologists, 2024
- Dr. Rajeeve
- New York median
- Medicare services
- 375vs 66844% below
- Medicare patients
- 104vs 21050% below
- Part D claims
- 370vs 25843% above
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Rajeeve's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rajeeve?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rajeeve and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Sridevi Rajeeve treated 104 Medicare patients in 2024, average age 73
CMS counts 104 Medicare patients who saw Dr. Rajeeve in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Rajeeve's median patient age at 72, with 49% women.
Dr. Rajeeve's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Rajeeve's Medicare patients by sex, 2024
- Women4240%
- Men6260%
Chronic conditions among Dr. Rajeeve's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis59%
- Chronic kidney disease38%
- Ischemic heart disease36%
- Anxiety35%
- Mood disorders32%
- Cancer31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Rajeeve's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women49%
- Men50%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Sridevi Rajeeve wrote 462 Medicare Part D claims in 2024
In 2024, Dr. Rajeeve wrote 462 Medicare Part D claims for 92 patients. 80% of them were for generic drugs. CMS names the drug for 370 of them, across 10 drugs with 11 or more claims each, at $1,986,936 in total drug cost. In 2023, CMS named 12 claims across 1 drug.
Dr. Rajeeve's Part D claims by kind of drug, 2024
- Generic370 claims80%
- Brand-name and other92 claims20%
Dr. Rajeeve's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Rajeeve's Part D claims, 2024
- Antibiotics3%13 of 462 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 122024: 3702983%
Drugs named by CMS: 10 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Sridevi Rajeeve scored 83 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Rajeeve for performance year 2024, reported as part of a group. Dr. Rajeeve accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rajeeve as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Rajeeve's MIPS scores, performance year 2024
- 83of 100Final score
- 80.9of 100Quality
- 40of 100Improvement Activities
- 65of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Sridevi Rajeeve has 19 publications on record
Dmand AI links 19 papers to Dr. Rajeeve, published from 2020 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Multiple Myeloma, Immunotherapy, Adoptive and Receptors, Chimeric Antigen. Dr. Rajeeve has published most often in Blood Adv. Dr. Rajeeve's most frequent co-authors are Saad Z. Usmani, MD, Sham Mailankody, MBBS and Michael Scordo.
Dr. Rajeeve's papers by year, 2020 to 2025
Topics Dr. Rajeeve writes about most
- Multiple Myeloma
- Immunotherapy, Adoptive
- Receptors, Chimeric Antigen
- Antibodies, Bispecific
- Antibodies, Monoclonal, Humanized
- B-Cell Maturation Antigen
- T-Lymphocytes
Dr. Rajeeve's most frequent co-authors
- Saad Z. Usmani, MD9 shared papers
- Sham Mailankody, MBBS8 shared papers
- Michael Scordo7 shared papers
Recent publications by Dr. Rajeeve
Clin Lymphoma Myeloma Leuk
See who Dr. Rajeeve researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rajeeve works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Sridevi Rajeeve received $6,282 in industry payments from 2021 to 2025
CMS Open Payments shows 26 general payments to Dr. Rajeeve from 8 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 74% of the total. Janssen Research & Development, LLC paid the most, $4,671.
General payments to Dr. Rajeeve by program year, 2021 to 2025
General payments to Dr. Rajeeve by kind, 2021 to 2025
- Consulting fees$4,67174%
- Food and beverage$1,47924%
- Education$1322%
Companies that paid Dr. Rajeeve the most, 2021 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Sridevi Rajeeve has 3 awards and honors on record
Dmand AI lists 3 awards for Dr. Rajeeve, most recently Young Investigator Award (YIA) in 2022.
Awards and honors for Dr. Rajeeve
- 2022
- Young Investigator Award (YIA)
- Undated
- Domestic Scholar Award
- HONORS Award and Grant
Source: Dmand AI Professional Profile Data
Dr. Sridevi Rajeeve graduated from Mahatma Gandhi University
Dr. Rajeeve graduated from Mahatma Gandhi University in 2015.
- Medical school
Source: Dmand AI Professional Profile Data
Dr. Sridevi Rajeeve accepts plans from 13 insurance carriers
Dr. Rajeeve is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Elevance
- Aetna
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Blue Cross Blue Shield of Massachusetts
- HCSC
- MVP Health Care
- Regence Health Plans
- +5 more carriersWith a free account
Plan types Dr. Rajeeve accepts, by number of carriers
- PPO9
- Medicare8
- POS5
- EPO4
- HMO4
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Sridevi Rajeeve's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Sridevi Rajeeve
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Sridevi Rajeeve's NPI number?
Dr. Sridevi Rajeeve's NPI number is 1154843944. It was assigned on July 13, 2017, and it is active in the NPI Registry.
What kind of doctor is Dr. Sridevi Rajeeve?
Dr. Sridevi Rajeeve is a hematologist and oncologist in New York, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Sridevi Rajeeve practice?
Dr. Rajeeve practices at 1275 York Avenue, New York, NY 10065. Dr. Rajeeve's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Rajeeve to 3 group practices and clinics and 2 medical groups.
What is Dr. Sridevi Rajeeve's medical license number?
Dr. Rajeeve holds New York license 311082.
Which hospitals is Dr. Sridevi Rajeeve affiliated with?
Dr. Rajeeve practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. Sridevi Rajeeve part of?
Dr. Rajeeve is linked to Memorial Hematology Lymphoma Group. Dmand AI links Dr. Rajeeve to 2 more medical groups.
Does Dr. Sridevi Rajeeve accept Medicare?
Yes. CMS data shows Dr. Rajeeve billed Medicare for 375 services in 2024, and Dr. Rajeeve accepts Medicare assignment.
Does Dr. Sridevi Rajeeve offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Rajeeve as offering telehealth services.
What is Dr. Sridevi Rajeeve's MIPS score?
Dr. Rajeeve's MIPS final score for performance year 2024 is 83 out of 100, reported as part of a group.
How many Medicare patients does Dr. Sridevi Rajeeve see?
CMS counts 104 Medicare patients who saw Dr. Rajeeve in 2024, with an average age of 73.
Show 8 more questionsShow fewer questions
What services does Dr. Sridevi Rajeeve bill to Medicare?
In 2024, Dr. Rajeeve's most billed Medicare services were office visit, established patient (99215), hospital inpatient care (99233) and medicare service (G0316).
Where did Dr. Sridevi Rajeeve go to medical school?
Dr. Rajeeve graduated from Mahatma Gandhi University in 2015.
What drugs does Dr. Sridevi Rajeeve prescribe most?
In 2024 Medicare Part D data, Dr. Rajeeve's most prescribed drugs by claims were Acyclovir, Lenalidomide and Pantoprazole Sodium.
Has Dr. Sridevi Rajeeve received payments from drug or device companies?
CMS Open Payments shows $6,282 in general payments to Dr. Rajeeve from 8 companies from 2021 to 2025. The largest total came from Janssen Research & Development, LLC.
How long has Dr. Sridevi Rajeeve been practicing?
Dr. Rajeeve graduated from medical school in 2015, 11 years ago.
Does Dr. Sridevi Rajeeve do research?
Dmand AI links 19 publications to Dr. Rajeeve, published from 2020 to 2025.
Who does Dr. Sridevi Rajeeve publish with?
Dr. Rajeeve's most frequent co-authors are Saad Z. Usmani, MD (9 shared papers), Sham Mailankody, MBBS (8 shared papers) and Michael Scordo (7 shared papers).
What insurance does Dr. Sridevi Rajeeve accept?
Dr. Rajeeve is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card